220 related articles for article (PubMed ID: 22527243)
1. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Guo G; Chen W; Liu XF; Zhang JY; Liu T; Luo P; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):1965-75. PubMed ID: 22527243
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer.
Liu T; Peng L; Yu P; Zhao Y; Shi Y; Mao X; Chen W; Cheng P; Wang T; Chen N; Zhang J; Liu X; Li N; Guo G; Tong W; Zhuang Y; Zou Q
J Clin Immunol; 2012 Dec; 32(6):1332-9. PubMed ID: 22760549
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Th22, Th17 and CD4
Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M
Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675
[TBL] [Abstract][Full Text] [Related]
4. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
5. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
6. Increased intratumoral interleukin 22 levels and frequencies of interleukin 22-producing CD4+ T cells correlate with pancreatic cancer progression.
Xu X; Tang Y; Guo S; Zhang Y; Tian Y; Ni B; Wang H
Pancreas; 2014 Apr; 43(3):470-7. PubMed ID: 24622082
[TBL] [Abstract][Full Text] [Related]
7. Human IL-21+IFN-γ+CD4+ T cells in nasal polyps are regulated by IL-12.
Xiao L; Jia L; Zhang Y; Yu S; Wu X; Yang B; Li H; Wu C
Sci Rep; 2015 Aug; 5():12781. PubMed ID: 26239551
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
Zhao L; Ma H; Jiang Z; Jiang Y; Ma N
Clin Exp Immunol; 2014 Jul; 177(1):212-8. PubMed ID: 24635166
[TBL] [Abstract][Full Text] [Related]
9. IL-35-producing B cells in gastric cancer patients.
Wang K; Liu J; Li J
Medicine (Baltimore); 2018 May; 97(19):e0710. PubMed ID: 29742730
[TBL] [Abstract][Full Text] [Related]
10. Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer.
Shan ZG; Chen J; Liu JS; Zhang JY; Wang TT; Teng YS; Mao FY; Cheng P; Zou QM; Zhou WY; Peng LS; Zhao YL; Zhuang Y
Clin Transl Med; 2021 Jun; 11(6):e484. PubMed ID: 34185422
[TBL] [Abstract][Full Text] [Related]
11. Th22 Cells Promote Osteoclast Differentiation
Miyazaki Y; Nakayamada S; Kubo S; Nakano K; Iwata S; Miyagawa I; Ma X; Trimova G; Sakata K; Tanaka Y
Front Immunol; 2018; 9():2901. PubMed ID: 30619268
[TBL] [Abstract][Full Text] [Related]
12. A High Frequency of Peripheral Blood IL-22(+) CD4(+) T Cells in Patients With New Onset Type 2 Diabetes Mellitus.
Guo H; Xu BC; Yang XG; Peng D; Wang Y; Liu XB; Cui CR; Jiang YF
J Clin Lab Anal; 2016 Mar; 30(2):95-102. PubMed ID: 25425169
[TBL] [Abstract][Full Text] [Related]
13. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.
Imperiale BR; García A; Minotti A; González Montaner P; Moracho L; Morcillo NS; Palmero DJ; Sasiain MDC; de la Barrera S
Clin Exp Immunol; 2021 Feb; 203(2):267-280. PubMed ID: 33128773
[TBL] [Abstract][Full Text] [Related]
14. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases.
Sarra M; Monteleone I; Stolfi C; Fantini MC; Sileri P; Sica G; Tersigni R; Macdonald TT; Pallone F; Monteleone G
Inflamm Bowel Dis; 2010 Aug; 16(8):1332-9. PubMed ID: 20186935
[TBL] [Abstract][Full Text] [Related]
16. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
17. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Peng D; Xu B; Wang Y; Guo H; Jiang Y
PLoS One; 2013; 8(7):e68446. PubMed ID: 23874630
[TBL] [Abstract][Full Text] [Related]
18. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4(+) Th cells to promote the development of IL-22-secreting Th cells.
Baba N; Rubio M; Kenins L; Regairaz C; Woisetschlager M; Carballido JM; Sarfati M
Hum Immunol; 2012 Aug; 73(8):795-800. PubMed ID: 22609446
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
Wu HQ; Zhao JJ; Li HW; Zhang Z
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
[No Abstract] [Full Text] [Related]
[Next] [New Search]